Posted in | News | Plastics and Polymers

An opportunity to tour MURA's first HydroPRS advanced plastic recycling site

On the 26th of October MURA invited various partners to explore their site before commissioning begins in early 2024. These partners included Igus, who were the first commercial business to invest back in 2020. The day consisted of various talks from stakeholders, including MURA CEO Dr Steve Mahon.

                                                                                                                                                                       Image Credit: MURA

Groups were then taken on a site tour led by members of the Project Development team who explained the HydroPRS process from start to finish.

"This fascinating day gave a real tangible insight into how plastics recycling will be part of a sustainable future. Thank you for the tour and welcome, Igus congratulates MURA on the successful construction of this plant”.

Matthew Aldridge, Igus UK Managing Director

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Igus UK. (2023, October 30). An opportunity to tour MURA's first HydroPRS advanced plastic recycling site. AZoM. Retrieved on April 28, 2024 from https://www.azom.com/news.aspx?newsID=62075.

  • MLA

    Igus UK. "An opportunity to tour MURA's first HydroPRS advanced plastic recycling site". AZoM. 28 April 2024. <https://www.azom.com/news.aspx?newsID=62075>.

  • Chicago

    Igus UK. "An opportunity to tour MURA's first HydroPRS advanced plastic recycling site". AZoM. https://www.azom.com/news.aspx?newsID=62075. (accessed April 28, 2024).

  • Harvard

    Igus UK. 2023. An opportunity to tour MURA's first HydroPRS advanced plastic recycling site. AZoM, viewed 28 April 2024, https://www.azom.com/news.aspx?newsID=62075.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.